(Q39006265)

English

Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect

scientific article published on 8 April 2014

Statements

Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect (English)
Charlotte Kopitz
Christoph A Schatz
Beatrix Stelte-Ludwig
Anke Mayer-Bartschmid
Kerstin Unterschemmann
Frank-Detlef Scholle
Beate Müller-Tiemann
Karl Ziegelbauer

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit